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Abstract 22 
 23 
Malaria is a widespread vector-borne disease infecting a wide range of terrestrial 24 
vertebrates including reptiles, birds and mammals. In addition to being one of the most deadly 25 
infectious diseases for humans, malaria is a threat to wildlife. The host immune system 26 
represents the main defence against malaria parasites. Identifying the immune effectors 27 
involved in malaria resistance has therefore become a major focus of research. However, this 28 
has mostly involved humans and animal models (rodents) and how the immune system 29 
regulates malaria progression in non-model organisms has been largely ignored. The aim of 30 
the present study was to investigate the role of nitric oxide (NO) as an immune effector 31 
contributing to the control of the acute phase of infection with the avian malaria agent 32 
Plasmodium relictum. We used experimental infections of domestic canaries in conjunction 33 
with the inhibition of the enzyme inducible nitric oxide synthase (iNOS) to assess the 34 
protective function of NO during the infection, and the physiological costs paid by the host in 35 
the absence of an effective NO response. Our results show that birds treated with the iNOS 36 
inhibitor suffered from a higher parasitaemia, but did not pay a higher cost of infection 37 
(anaemia). While these findings confirm that NO contributes to the resistance to avian malaria 38 
during the acute phase of the infection, they also suggest that parasitaemia and costs of 39 
infection can be decoupled. 40 
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 47 
1. Introduction 48 
 49 
Malaria protozoa still severely threaten the health of human populations, causing 50 
around 700,000 of deaths worldwide in 2010 (World Health Organization, 2011). The 51 
negative health implications of Plasmodium infections have stimulated considerable attention 52 
on the study of immunity to malaria (see for instance Doolan et al., 2009; Langhorne et al., 53 
2008), in both humans, who are obviously less amenable to experimental approaches, and in 54 
animal models (Artavanis-Tsakonas et al., 2003). Thus, the current knowledge of the 55 
immunological pathways involved in resistance/tolerance of malaria infection comes mainly 56 
from rodent malaria models, Plasmodium chabaudii, P. berghei and P. yoelii (Good and 57 
Doolan, 1999; Langhorne et al., 2004; Roetynck et al., 2006).  58 
Plasmodium parasites have a complex life cycle involving a mosquito vector, in which 59 
sexual reproduction of the pathogen occurs, and a vertebrate host in which the parasite 60 
reproduces asexually. Invertebrates and vertebrates differ in many aspects of their immune 61 
system which might impose a challenge to the parasite in terms of its ability to adapt to 62 
different immunological environments (Hammerschmidt and Kurtz, 2005). However, both 63 
hosts share some immunological pathways, in particular the innate arm of the immune system 64 
where cytotoxic compounds are released shortly after the infection (i.e. nitric oxide).  65 
Immunity of vertebrate hosts to malaria involves a complex network of immunological 66 
effectors. The control of the acute phase of the infection (peak parasitaemia being reached 67 
between 8 and 16 days post-infection, depending on the model system considered) depends on 68 
the activation of a helper T-cell 1 (Th1) response (Taylor-Robinson et al., 1993). Pro-69 
inflammatory cytokines, such as tumor necrosis factor- (TNF- and interferon- (IFN-, 70 
are produced and released with the further activation of macrophages that release cytotoxic 71 
compounds. The acute phase of the infection is then followed by a chronic phase with very 72 
low parasitaemia eventually leading to recurrent relapses (Huldén et al., 2008). The shift from 73 
acute to chronic infection is paralleled by a shift from a Th1 to a helper T-cell 2 (Th2) 74 
response, with the production of immunoglobulins (IgGs) specific to the current parasite 75 
strains (Taylor-Robinson and Looker, 1998; Taylor-Robinson et al., 1993). Multiple 76 
exposures to malaria parasites therefore lead to a partial immunity that has been called 77 
premunition (Soe et al., 2001), whereas total immunity is probably prevented by the antigenic 78 
variation of malaria parasites producing variants that escape the pre-existing antibody 79 
repertoire (Newbold, 1999). 80 
In addition to humans (and non-human primates) and rodents, malarial parasites are 81 
widespread pathogens of birds and reptiles (Valkiūnas, 2005), principally in tropical and 82 
temperate areas. Avian malaria is thought to be non-lethal in hosts that have a long co-83 
evolutionary relationship with the parasite (Fallis and Desser, 1977). Nevertheless, recent 84 
experimental infections have also shown that avian malaria parasites can be costly and 85 
substantially reduce host fitness (Knowles et al., 2010; Palinauskas et al., 2008, 2009; 86 
Zehtindjiev et al., 2008). Moreover, immunologically naïve and domestic populations can 87 
have large significant negative consequences of infection in terms of mortality, raising both 88 
conservation and economic concerns (Atkinson, 1999; Atkinson and Van Riper III, 1991; 89 
Cellier-Holzem et al., 2010; Van Riper et al., 1986; Williams, 2005). The introduction of 90 
malaria parasites to the Hawaii archipelago is the classical example of the impact of 91 
Plasmodium on natural populations of birds that have no co-evolutionary history with the 92 
parasite. Upon introduction of the mosquito vector, endemic bird species became infected 93 
with Plasmodium relictum and experienced a dramatic decline in number, due to high 94 
infection-induced mortality (Atkinson et al., 1995; Van Riper et al., 1986). Interestingly, a 95 
few years after the introduction of the pathogen, local bird populations now seem better able 96 
to tolerate the infection while paying much smaller costs  (Woodworth et al., 2005). Similarly, 97 
infection of domestic birds (i.e., chickens) with Plasmodium gallinaceum can lead to very 98 
high mortality depending on the age of the host (young chicks may suffer up to 80% 99 
mortality) and the inoculum size (Williams, 2005).    100 
In spite of the importance of avian malaria for the functioning of natural populations 101 
and domestic animals, immunity to avian malaria has been poorly studied. In the last decade, 102 
a few studies have reported a number of associations between major histocompatibility 103 
complex (MHC) alleles and Plasmodium prevalence and parasitaemia (Bonneaud et al., 2006; 104 
Loiseau et al., 2008, 2011; Westerdahl, et al., 2005, 2012). However, experimental 105 
approaches are mostly lacking. 106 
Among the possible effectors that might contribute to the control of the acute phase of 107 
the infection, nitric oxide is a very good candidate. Nitric oxide (NO) is a highly reactive and 108 
unstable free-radical gas that is produced by the oxidation of L-arginine to citrulline by the 109 
enzyme inducible NO synthase (iNOS) (Vincendeau et al., 2003). iNOS is rapidly synthesized 110 
by a wide array of cells and tissues in response to pro-inflammatory cytokines produced 111 
during the infection (Rivero, 2006). NO has both suppressive and stimulatory functions: it 112 
inhibits and promotes cell proliferation, it modulates the production of cytokines, chemokines 113 
and growth factors, and it directly acts as a non-specific cytotoxic effector molecule (Bogdan 114 
et al., 2000). Previous work has shown that NO has a cytostatic (cessation of growth) and 115 
cytotoxic effect on different Plasmodium species both in vitro and in vivo) (Taylor-Robinson, 116 
1997; Taylor-Robinson and Looker, 1998; Taylor-Robinson and Smith, 1999). Interestingly, 117 
NO is an immune effector shared by both vectors and vertebrate hosts (Rivero, 2006). 118 
Epidemiological studies have also reported negative correlations between severity of 119 
malaria infection in children and iNOS expression (Anstey et al., 1996). Similarly, in the 120 
mosquito vector, induction of iNOS expression contributes to control infection with 121 
Plasmodium parasites (Luckhart et al., 1998; Peterson et al., 2007). Evidence for avian hosts 122 
is, however, restricted to a single study where in vivo NO production by macrophages isolated 123 
from chickens infected with Plasmodium gallinaceum was positively correlated with 124 
parasitaemia (Macchi et al., 2010).  125 
In this article, we wished to explore experimentally the role plaid by NO in the 126 
regulation of the acute phase of the infection with Plasmodium relictum in domestic canaries 127 
(Serinus canaria). This was achieved by using the specific iNOS inhibitor aminoguanidine 128 
(AG) (Allen, 1997; Wideman et al., 2006). In addition to assessing parasitaemia in AG-129 
treated and control hosts, we also measured the cost of infection in the absence of a functional 130 
NO response.   131 
  132 
2. Material and methods 133 
 134 
2.1 Bird husbandry 135 
 136 
The experiment was conducted during the autumn of 2009. Birds were kept in 137 
individual cages (0.6 x 0.4 x 0.4 m), with food (commercial seed mix, Versele-Laga, 138 
Belgium), grit and water provided ad libitum. The temperature was kept constant (21 ± 1°C), 139 
under a controlled daily light cycles (LD 13:11 h). The birds originated from a bird breeder 140 
and were kept under the above conditions three weeks before the start of the experiment. 141 
  The experiments were performed under the licence # 21-CAE-085 delivered by the 142 
departmental veterinary service. 143 
 144 
2.2 Experiment 1: Experimental inhibition of the NO response  145 
 146 
To check whether AG has an inhibitory effect on the iNOS as reported for chickens, 147 
we performed an experiment where non-infected domestic canaries were either treated with 148 
AG [intraperitoneal injection of 1mg AG dissolved in 100 µL of phosphate buffer saline 149 
(PBS)] or kept as control and injected with the same volume of PBS. Within each of these 150 
treatments, half of the birds had their inflammatory response stimulated by an intraperitoneal 151 
injection of Escherichia coli lipopolysaccharide (LPS) (0.02mg dissolved in 100 µL of PBS), 152 
whereas the other half received a same volume PBS injection. Each experimental group 153 
contained 9 birds. We took a blood sample (ca 100 µL) from the brachial vein before the 154 
treatment started (h0) and after nine hours (h9) to measure plasmatic concentrations of NO. 155 
Nine hours post-challenge corresponds to the peak of LPS-induced NO production (Takahashi 156 
et al., 1999).  157 
NO production was indirectly measured using the Griess reaction. Because of the very 158 
short half life of nitric oxide (few seconds) in biological tissues, NO was measured by 159 
quantifying nitrates (NO3
-) and nitrites (NO2
-) (NOx). NOx were produced during the reaction 160 
with different oxygen species (Sild and Horak, 2009). First, ZnSO4 and NaOH solutions were 161 
added to deproteinize the plasma. The supernatant produced by this reaction was recovered 162 
and a glycine buffer was added. In the second step, nitrate was reduced to nitrite by using 163 
cadmium granules, activated with sulfuric acid and CuSO4 solutions. The last step consists in 164 
the Griess reaction, in which plasma products were put in a microplate and Griess reagent 165 
(sulphanilamide and N-naphtylethylene-diamine) was added. The microplate was placed into 166 
a spectrophotometer at 25°C, under shaker. Spectrophotometric measurements were done at 167 
540nm and measures were taken every 5 minutes for 30 minutes (SPECTRAMaxPLUS384, 168 
Molecular Devices). We used the optical density (OD) values at 30 minutes. NOx 169 
concentrations were determined using a standard curve of known nitrate concentration. 170 
Standards were obtained by successive dilutions of a NO3- solution at 100µM. A full 171 
description of the method can be found in Sild and Horak (2009).   172 
    173 
2.3 Experiment 2: Effects of aminoguanidine on parasitaemia and cost of infection 174 
 175 
Parasites used for the experimental infections were obtained from a natural population 176 
of house sparrows (Passer domesticus) in Dijon, France and cryopreserved at -80°C. Blood 177 
(ca. 200 µl) of SGS1 infected house sparrows [as detected by a nested PCR method 178 
(Waldenström et al., 2004) that amplifies a section of the mitochondrial cytochrome b gene 179 
and sequencing of the PCR products] was intraperitoneally injected into domestic canaries. At 180 
day 10 post-infection, blood of infected canaries was cryopreserved using the protocol 181 
described in Diggs et al. (1975). Briefly, fresh infected heparinized blood was centrifuged at 182 
800g for 5 minutes and the supernatant removed. A cryopreserving solution (6.2M glycerol + 183 
0.14M Na lactate + 0.0005M KCl + PBS to 500ml) was added dropwise with gentle vortexing 184 
to packed red blood cells at 4 to 1 volumes. Blood was then stored at -80° C. For the present 185 
experiment, cryopreserved blood was thawed at 37° without agitation for 2 minutes. We then 186 
added 0.2 volume of 12% NaCl (dropwise with gentle vortexing), allowed to stand for 5 187 
minutes and added 9 volumes of 1.6% NaCl dropwise as above. Blood was then centrifuged 188 
for 5 minutes at 650g and the pellet resuspended in PBS.  189 
Thawed blood was directly transferred intraperitoneally into five domestic canaries, 190 
using 0.5 ml insulin syringes, in order to increase parasite intensity. Eleven days after 191 
infection, we measured the haematocrit of these five birds and prepared blood smears for 192 
microscopic examination. Smears were made by spreading a drop of blood from each bird on 193 
a glass slide, fixing with absolute methanol and then staining with 10% Giemsa solution 194 
(Sigma–Aldrich). We counted the number of asexual infectious stages of the parasite 195 
observed in a total of 10,000 erythrocytes. Parasite intensities and haematocrit allowed us to 196 
evaluate the number of parasites per µl of blood for each bird (a haematocrit of 50% 197 
corresponded approximately to 5,000,000 erythrocytes per microliter of blood). We collected 198 
blood from donors, which was subsequently diluted in 0.9% saline solution to obtain the 199 
desired number of parasites per inoculum. 200 
In a 2-way factorial design, we investigated the effects of AG, and hence the effect of 201 
NO synthesis inhibition, on parasitaemia of P. relictum. For this purpose, 60 non-infected 202 
canaries were randomly distributed among four experimental groups (n = 15 per group). At 203 
day 0, the first group was intraperitoneally inoculated with a dose of 1 x 106 parasites (lineage 204 
SGS1) and received a daily injection of 1mg of AG (in 100 µl of PBS) until day 15 post-205 
infection (AG+/P+). The second group was infected with the same sized parasite inoculum but 206 
only received a daily injection of 100 µl of PBS (AG-/P+). The third group was sham-infected 207 
and received the same daily injection of AG as group 1 (AG+/P-). The final group served as a 208 
double negative control since birds were sham infected and received a daily injection of PBS 209 
(AG-/P-). Sham infection was performed by injecting a volume of PBS (50 µl) corresponding 210 
to the volume of parasite inoculum. Previous work has shown that injecting PBS represents an 211 
appropriate control similar to injecting non-infected blood (Cellier-Holzem et al., 2010).  212 
Birds were monitored at day 5, 8, 10, 14 and 17 post-infection. At each of these time 213 
points, we recorded body mass to the nearest 0.1 g and we collected a blood sample from the 214 
left brachial vein using heparinized capillaries. Twenty microliters were used to assess 215 
haematocrit after centrifugation for 5 min at 10,000 rpm; 20µl were flushed with 500 µl of 216 
Queen Lysis Buffer for parasite quantification.  217 
Parasitaemia was assessed using a quantitative PCR, following the protocol described 218 
in Cellier-Holzem et al. (2010). For each individual we conducted two qPCR reactions in the 219 
same run: one targeting the nuclear 18s rDNA gene of Plasmodium (Primers 18sPlasm7 (5’-220 
AGC CTG AGA AAT AGC TAC CAC ATC TA-3’), 18sPlasm8 (5’-TGT TAT TTC TTG 221 
TCA CTA CCT CTC TTC TTT-3’), and fluorescent probe Plasm Hyb2 (5’-6FAM-CAG 222 
CAG GCG CGT AAA TTA CCC AAT TC-BHQ1-3’)); and the other targeting the 18s rDNA 223 
gene of birds (Primers 18sAv7 (5’-GAA ACT CGC AAT GGC TCA TTA AAT C-3’), 224 
18sAv8 (5’-TAT TAG CTC TAG AAT TAC CAC AGT TAT CCA-3’) and fluorescent probe 225 
18sAv Hyb (5’-VIC-TAT GGT TCC TTT GGT CGC TC-BHQ1-3’)). Parasite intensities 226 
were calculated as relative quantification values (RQ) as 2-(Ct 18sPlasmodium – Ct 18s Bird) using the 227 
software SDS 2.2 (Applied Biosystem). Ct represents the number of PCR cycles at which 228 
fluorescence is first detected as statistically significant above the baseline and RQ can be 229 
interpreted as the fold-amount of target gene (Plasmodium 18s rDNA) with respect to the 230 
amount of the reference gene (host 18s rDNA). All qPCR reactions were carried out in an 231 
ABI Prism 7900 cycler (Applied Biosystem). 232 
 233 
2.4 Statistical analyses 234 
 235 
2.4.1 Experiment 1: experimental inhibition of the NO response by aminoguanidine 236 
 237 
 The effect of treatments on NOx concentration (log-transformed) at h0 and h9 was 238 
investigated using a Kruskal-Wallis test.     239 
 240 
2.4.2 Experiment 2: Effects of aminoguanidine on parasitaemia and cost of infection  241 
 242 
Changes in log-transformed parasitaemia were modelled using a Generalized Linear 243 
Mixed Model (GLMM) with a beta distribution of errors (Duerr et al., 2004). Time post-244 
infection, squared time post-infection, treatment (AG vs control) and the two-way interactions 245 
(time * treatment, squared time * treatment) were included as fixed factors. Individual 246 
identity was declared as a random factor to take into account the repeated measures of 247 
individuals. Degrees of freedom were corrected using the Satterthwaite method. Obviously, 248 
this analysis only concerned experimentally infected birds. 249 
The physiological cost of infection was assessed by changes in body mass and 250 
haematocrit during the course of the experiment. For our measures of parasitaemia, we used 251 
GLMMs with a normal distribution of errors and Satterthwaite correction for degrees of 252 
freedom. The models included time post-infection, squared time post-infection, treatment 253 
(AG vs. control), infectious status (infected vs non-infected), the two- and three-way 254 
interactions as fixed effects. Individual identity was declared as a random effect.  255 
All tests were performed using SAS v.9.2 (SAS 2002) 256 
 257 
3. Results 258 
 259 
3.1 Experiment 1: experimental inhibition of the NO response by aminoguanidine 260 
 261 
At time h0, NOx concentration did not differ among the four groups (X²3=3.21, 262 
P=0.36). At time h9, the AG-/LPS+ group had a statistically significant higher NOx 263 
concentration than the AG+/LPS+ group (X²3=8.57, P=0.036) (Fig.1). 264 
 265 
3.2 Experiment 2: Effects of aminoguanidine on parasitaemia and cost of infection 266 
 267 
Parasitaemia of experimentally infected birds not treated with AG showed the 268 
expected bell-shaped variation with time, reaching a peak at day 14 pi. Parasitaemia of AG-269 
treated birds, however showed a steady increase (with the exception of day 11 pi), with peak 270 
parasitaemia being reached at day 17 pi. This resulted in a statistically significant interaction 271 
between squared time and treatment (Table 1, Fig. 2).  272 
Infection was costly in terms of haematocrit. Infected birds suffered a clear drop in 273 
haematocrit with minimum values reached at day 11 pi, whereas the haematocrit level of non-274 
infected birds remained constant through the experimental period (Fig. 3). This resulted in a 275 
statistically significant interaction between squared time and infectious status (Table 2). 276 
Interestingly, however, variation in haematocrit did not depend on the aminoguanidine 277 
treatment (Table 2), in spite of infected, AG-treated birds having higher parasitaemia. 278 
Body mass was not affected by either infectious status nor AG treatment (Table 3).    279 
 280 
4. Discussion 281 
 282 
The aim of this study was to experimentally assess the contribution of a specific 283 
immunological pathway (the NO response) to the control of Plasmodium relictum (lineage 284 
SGS1) parasitaemia in domestic canaries. Even though aminoguanidine has already been 285 
shown to be an effective inhibitor of iNOS in chickens (Wideman et al., 2006), we first 286 
wished to check whether its inhibitory function was preserved in domestic canaries. In 287 
agreement with the results reported for chickens, we found that LPS injected birds had a 288 
smaller NO response when simultaneously injected with AG. It is worthwhile to note that the 289 
inhibitory effect was not total and AG-treated birds did produce some NO upon stimulation 290 
with LPS.  291 
AG-treated canaries were less able to control the acute phase of infection with 292 
Plasmodium relictum compared to control animals, suggesting that NO contributes to the 293 
immunological defences deployed during the infection with avian malaria. This is in 294 
agreement with previous results involving other malaria parasites infecting mammalian hosts 295 
(see Taylor-Robinson, 2010 for a recent review). Our results therefore corroborate the well-296 
established idea that NO has important anti-parasitic properties. Several studies have used 297 
similar experimental approaches to manipulate the NO response in insects and vertebrates. 298 
For instance, in the mosquito Anopheles gambiae, the inhibition of nitric oxide with inert L-299 
arginine leads to a decrease in the ability of mosquitos to kill Escherichia coli bacteria 300 
(Hillyer and Estevez-Lao, 2010). In another mosquito species, Anopheles stephensi, a 301 
provision of the NOS substrate, L-ARGININE, reduced Plasmodium infections, whereas a 302 
dietary provision of the NO inhibitor L-NAME significantly increased parasite burden 303 
(Luckhart et al., 1998). Moreover, nitric oxide is associated with Plasmodium ookinete lysis 304 
(Peterson et al., 2007). In vertebrates, the role of NO as an effective immune effector against 305 
malaria has only been explored in humans (Anstey et al., 1996; Hobbs et al., 2002) and mice 306 
(Taylor-Robinson, 2010). Wang et al. (2009) showed that mice experimentally infected with 307 
Plasmodium yoelii exhibit an increase in NO which coincides with a decrease in parasitaemia. 308 
Some authors have even suggested that supplementation with the nitric oxide synthetic 309 
metabolite (S-nitrate) could be used as a therapy against Plasmodium infection (Nahrevanian 310 
et al., 2008).  311 
Although our finding that AG-treated birds suffered from increased parasitaemia 312 
strongly suggests a role for NO in the control of the acute phase of the infection with 313 
Plasmodium relictum, a definitive conclusion cannot be drawn without measuring NO 314 
production following the experimental infection. We did not have a clear prediction on when 315 
would be the best time to measure NO during the infection period. Ideally, we would have 316 
measured NO on a daily basis but daily blood sampling would have certainly induced too 317 
much stress. Future work should nevertheless be directed towards establishing the link 318 
between NO production and parasitaemia in this system. 319 
In spite of their increased parasitaemia, AG-treated birds did not seem to pay a higher 320 
cost of infection compared to control individuals. Haematocrit level, body mass and mortality 321 
(only 4 birds died during the experiment, one in AG+/P- group, one in AG+/P+ group, and two 322 
in AG-/P+ group) did not differ between AG-treated and control hosts. A visual inspection of 323 
figure 3 suggests that AG-treated birds have a lower haematocrit especially at day 14 and 17 324 
p.i., that is when parasitaemia reaches its maximum values. However, there is no statistical 325 
support to the idea that AG-treated birds had a lower haematocrit compared to control 326 
individuals. Even when restricting the analysis to infected birds, the difference in haematocrit 327 
between AG- and AG+ individuals was very far from reaching the significance threshold (time 328 
p.i. * AG treatment, F1,131 = 0.11, p = 0.740; squared time p.i. * AG treatment, F1,130 = 0.33, p 329 
= 0.564). These results might appear somewhat puzzling because infection does incur costs in 330 
our model system, especially in terms of reduction in haematocrit level (Cellier-Holzem et al., 331 
2010; the present study). A reduction in haematocrit is partly the direct consequence of the 332 
asexual reproduction of the parasites within the red blood cells and the subsequent lysis and 333 
release of merozoites in the blood stream. Since haematocrit levels and parasitaemia are 334 
usually negatively correlated (the more parasites, the more lysis of red blood cells takes place) 335 
we should have expected that AG-treated birds paid a higher cost of infection. Anaemia and 336 
haematocrit reduction could also partly arise as a consequence of immune responsiveness, 337 
with immune effectors targeting infected red blood cells. Indeed, in a rodent malaria system, 338 
it has been estimated that 10% of anaemia is due to an over-reacting immune response 339 
(Graham et al., 2005b). We might then speculate that inhibiting the NO response produced 340 
two counter-balancing effects: increased parasitaemia enhances the cost of infection, but 341 
reduced NO production also reduces the costs of the immune defence.  342 
These results can feed the current debate on the relationship between parasite 343 
multiplication and virulence (the trade-off model for the evolution of parasite virulence) and 344 
the role played by immunopathology as a major determinant of virulence (Alizon et al., 2009; 345 
Day et al., 2007; Graham et al., 2005a; Long and Graham, 2011).  Nevertheless, the idea that 346 
down-regulating the immune response decouples the cost of infection from parasitaemia 347 
undoubtedly requires further work to be fully established.   348 
We found no effect of Plasmodium infection and AG treatment on body mass. Benign 349 
environmental conditions, with ad libitum food and water, and constant temperature, might 350 
contribute to explain this result. Interestingly, other studies based on experimental infection of 351 
European passerines in the lab have reported a similar lack of effect of infection on body mass 352 
(Palinauskas et al., 2008, 2011; Zehtindjiev et al., 2008). These results suggest that, in 353 
addition to the role plaid by favourable environmental conditions, a lost in body mass is not 354 
include in the physiological costs of infection with Plasmodium relictum for birds that have 355 
coevolved with the parasite. A different picture emerges for host species that did not coevolve 356 
with the parasite, as shown by the experimental infection of Hawaiian birds with Plasmodium 357 
relictum. Both Myadestes obscurus and Hemignathus virens have been shown to suffer from a 358 
substantial decrease in body mass following the infection with Plasmodium relictum 359 
(Atkinson et al., 2000, 2001). 360 
Parasitaemia was highly variable among infected birds. Among-individual variation in 361 
parasite intensity is a common finding (Cellier-Holzem et al., 2010; Palinauskas et al., 2009; 362 
Zehtindjiev et al., 2008), and multiple sources may account for this Individual hosts vary in 363 
their genetic background and this can shape their susceptibility to infection (Bonneaud et al., 364 
2006; Loiseau et al., 2008, 2011; Westerdahl, et al., 2005, 2012). In addition host age and sex 365 
might also contribute to generate among-individual variation in parasite intensity (McCurdy 366 
et al., 1998; Sol et al., 2000; Williams, 2005). 367 
Vector borne parasites have to face and adapt to different environments (the vector 368 
and the host) to complete their life cycle. Shared immunological pathways between the vector 369 
and the host could therefore be the main target of immune-mediated selection acting on the 370 
parasite. Nitric oxide is one such shared immunological pathway, and we might expect 371 
parasites to evolve strategies to escape the NO produced in response to infection. Indeed, it 372 
has been suggested that some protozoa (Trypanosoma cruzi and Leishmania major) can 373 
deplete the substrate of the NOS (L-arginine) by activating arginases (Vincendeau et al., 374 
2003). Whether Plasmodium parasites have evolved the same escape strategy remains an open 375 
question.  376 
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Figure captions 568 
 569 
Fig. 1. Mean (+ SE) NOx concentration in domestic canaries that were injected with LPS (or 570 
PBS as a control) and with aminoguanidine (AG) (or PBS as a control), giving rise to four 571 
experimental groups (AG-/LPS+, AG+/LPS+, AG-/LPS-, AG+/LPS-). NOx was measured 9 572 
hours post-challenge.  573 
 574 
Fig. 2. Changes in parasitaemia (mean ± SE) during the course of the experiment. Triangles 575 
represent birds in the AG-/P+ group, and dots birds in the AG+/P+ group.  576 
 577 
Fig. 3. Variation in haematocrit (mean ± SE) during Plasmodium relictum infection. Solid 578 
lines and black triangles represent birds in the AG-/P+ group, dashed lines and white triangles 579 
birds in the AG-/P- group, solid lines and black dots birds in the AG+/P+ group, and dashed 580 
lines and white dots birds in the AG+/P- group. 581 
